Skip to main content

Table 1 Baseline characteristics for groups with and without subchorionic hematoma (SCH)

From: The impact of first-trimester subchorionic hematomas on pregnancy outcomes after euploid embryo transfer: a retrospective cohort study

Variable

SCH (n = 298)

Non-SCH (n = 1241)

P-value

Maternal age (y)

32.3 ± 4.7

32.2 ± 4.8

0.561

BMI (kg/m2)

23.5 ± 3.3

23.8 ± 3.4

0.070

AMH (ng/mL)

3.5 (1.8, 6.1) (290) a

3.6 (2.0, 6.0) (1220) a

0.497

chromosomal abnormalities

for PGT-SR

107(35.9)

497(40.0)

0.189

No. of Previous miscarriage

  

0.776

0

88 (29.5)

388 (31.3)

 

1

67 (22.5)

272 (21.9)

 

2

72 (24.2)

269 (21.7)

 

≥ 3

71 (23.8)

312 (25.1)

 

Basal hormone levelsb

   

Follicle-stimulating hormone (IU/liter)

6.5 ± 1.9

6.4 ± 1.9 (1239) a

0.746

Luteinizing hormone (IU/liter)

6.1 ± 4.6

5.6 ± 3.6 (1239) a

0.140

Estradiol (pg/ml)

36.5 (27.4, 49.2) (297) a

34.8 (26.8, 44.4) (1229) a

0.027

Ultrasonographic findingsc

   

AFC

16.9 ± 8.8

16.4 ± 8.2 (1236) a

0.338

PCO

81 (27.2)

326 (26.3)

0.749

Uterine fibroids

51 (17.1)

217 (17.5)

0.879

Vaginal bleeding

67 (22.5)

144 (11.6)

<0.001

  1. Data are presented as mean ± standard deviation or median (interquartile range) or n (%) unless otherwise specified. AFC, antral follicle count; AMH, anti-Mullerian hormone; BMI, body mass index; PCO, polycystic ovaries; SCH, subchorionic hematoma
  2. aNumber in brackets represents the number of observations that was less than the total patient number in the group
  3. bThe baseline steroid hormones were measured at the early follicular phase, mostly on day 1 to 3 of the menstrual cycle
  4. cUltrasound is performed at the early follicular phase, mainly on days 1–3 of the menstrual cycle